Navigation Links
Oncolytics Biotech(R) Inc. Announces Issuance of 32nd U.S. Patent
Date:9/1/2009

CALGARY, Sept. 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted its 32nd U.S. Patent, # 7,582,289, entitled "Viruses for the Treatment of Cellular Proliferative Disorders." The patent claims cover methods of using modified parapoxvirus orf virus to treat Ras-mediated cancers.

"This U.S. patent expands our intellectual property portfolio regarding oncolytic viruses, in addition to reovirus, that can be modified to grow selectively in Ras-mediated cancers," said Mary Ann Dillahunty, Vice President of Intellectual Property for Oncolytics. "Including the patent issued today, Oncolytics has now secured five U.S. patents covering the use of other oncolytic viruses to treat Ras-mediated cancers. Patents covering similar subject matter have been granted in other jurisdictions as well."

    U.S. Patents issued previously include:

    -   U.S. Patent # 6,596,268, which covers adenoviruses modified in the
        VAI gene;

    -   U.S. Patent # 7,344,711, which covers adenoviruses modified in the
        VAI and VAII genes;

    -   U.S. Patent # 6,649,157, which covers herpes simplex virus (HSV)
        mutated in the ?134.5 gene; and

    -   U.S. Patent # 7,252,817, which covers modified HSV, where the ?
        134.5 gene is lacking, inhibited or mutated such that PKR activation
        is not blocked.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For furt
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013 zuChem Inc., ... health and nutrition, announced today that the United ... 2 patents - US 8,367,346 entitled “Methods for ... entitled "Process for producing D-Mannitol." These two patents ... of natural food sweetener products from abundant, renewable ...
(Date:6/17/2013)... Z Trim Holdings, Inc. (OTC Markets: ... ingredients to a variety of industries, today announced ... application at this year,s annual Institute of Food ... , July 13-16. The Company will demonstrate how ... in meat products thereby helping manufacturers lower costs ...
(Date:6/17/2013)... 17, 2013 Yongye International, Inc. (NASDAQ:   ... and distributor of crop nutrient products in ... today that its common stock will resume trading on ... at 7:15 a.m. Eastern Time. As previously ... Monday, March 18, 2013 following Yongye,s notification that the ...
(Date:6/16/2013)... CO (PRWEB) June 16, 2013 This training ... the Scrum team, people outside the software industry or those ... of what it is. , The topics that will ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... the following cities: , Denver, CO June 28, 2013 , ...
Breaking Biology Technology:zuChem Receives Two Polyol Patents 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2
... /Xinhua-PRNewswire/ -- Tiens Biotech Group (USA),Inc. (the "Company" or ... for the second quarter and six months ended,June 30, ... 2008, revenue was $19.7 million,an increase of 37.2% compared ... Net income for the second quarter of 2008 ...
... - Company to Host Conference Call at 4:30 p.m. ET ... PCYC ) today reported financial results for its fourth ... for the fourth quarter of,fiscal 2008 was $4.6 million, or ... or $0.27 per share, for the fourth quarter of fiscal ...
... improvements for converting plant biomass into biofuelas an alternative ... Eddy Rubin, Director of the U.S. Department of Energy ... edition of the journal Nature . In ... forward for how emerging genomic technologies will contribute to ...
Cached Biology Technology:Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 2Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 3Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 4Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 5Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 6Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 7Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 8Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 9Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 10Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 11Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 12Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 13Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 14Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 2Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 3Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 4Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 5Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 6DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 2DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 3DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature 4
(Date:6/17/2013)... Boston, MA Women in the U.S. exposed to high ... as likely to have a child with autism as women ... new study from Harvard School of Public Health (HSPH). It ... autism and air pollution across the U.S. , "Our findings ... of the women in our study lived in areas where ...
(Date:6/17/2013)... Vietnam and other locations with central nervous system infections ... newly discovered virus, according to a study to be ... of the American Society for Microbiology. Researchers have detected ... 642 patients with central nervous system infections of unknown ... fecal samples from pigs and poultry, suggesting animals may ...
(Date:6/17/2013)... identified a new virus in patients with severe brain ... whether the virus is responsible for the symptoms of ... of 28 out of 644 patients with severe brain ... not in any of the 122 patients with non-infectious ... brain and central nervous system are often fatal and ...
Breaking Biology News(10 mins):Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3
... found that some individuals in the vegetative and minimally ... themselves, can learn and thereby demonstrate at least a ... (20 September) online edition of Nature Neuroscience . ... tested whether patients in vegetative and minimally conscious states ...
... assistant researcher Durrell Kapan recently published a paper, Man ... Vector-Borne Disease Dynamics, in PLoS One . ... patterns in mega-cities may be a critically overlooked factor ... dengue fever, infecting 50-100 million people annually. "Even ...
... conditions, such as chronic pain, cancer and diabetes, require medications ... on an as-needed basis, over a long period of time. ... heat source, an implanted electronic chip or other stimuli as ... But thus far, none of these methods can reliably do ...
Cached Biology News:Scientists find that individuals in vegetative states can learn 2UH Manoa researcher examines possible implications of daily commute and mosquito-borne diseases 2Using magnetism to turn drugs on and off 2